Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Kirk Somers. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Kirk Somers har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:CDLX / Cardlytics, Inc. | Chief Legal & Privacy Officer | 52 130 |
US:GKNT / Geeknet, Inc | EVP, General Counsel and CAO | 1 806 |
US:CCUR / CCUR Holdings, Inc. | EVP and Secretary | 48 877 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Kirk Somers. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CCUR / CCUR Holdings, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CCUR / CCUR Holdings, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CCUR / CCUR Holdings, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp CDLX / Cardlytics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CCUR / CCUR Holdings, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CCUR / CCUR Holdings, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Kirk Somers som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 52 130 | −1,88 | 13,91 | −13 910 | 725 128 |
2022-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 7 813 | 53 130 | 17,24 | ||||
2022-06-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 45 317 | −2,16 | 25,05 | −25 050 | 1 135 191 |
2022-05-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 46 317 | −2,11 | 25,25 | −25 250 | 1 169 504 |
2022-05-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 400 | 47 026 | −6,74 | 34,66 | −117 844 | 1 629 921 | |
2022-05-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 332 | 50 426 | −6,20 | 34,16 | −113 821 | 1 722 552 | |
2022-04-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −177 | 53 758 | −0,33 | 46,77 | −8 278 | 2 514 262 |
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −7 813 | 7 812 | −50,00 | ||||
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 7 813 | 53 935 | 16,94 | ||||
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −1 704 | 5 114 | −24,99 | ||||
2022-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 1 704 | 46 122 | 3,84 | ||||
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −8 468 | 16 935 | −33,33 | ||||
2022-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 8 468 | 44 418 | 23,55 | ||||
2022-03-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
A - Award | 1 660 | 35 950 | 4,84 | ||||
2022-03-24 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 18 598 | 25 416 | 272,78 | ||||
2022-03-16 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 34 290 | −2,83 | 42,82 | −42 820 | 1 468 298 |
2022-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 35 290 | −2,76 | 68,46 | −68 460 | 2 415 953 |
2022-01-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 36 290 | −2,68 | 67,97 | −67 970 | 2 466 631 |
2021-12-16 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 000 | 37 290 | −2,61 | 66,26 | −66 260 | 2 470 835 |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 475 | 38 290 | −3,71 | 69,65 | −102 734 | 2 666 898 | |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 600 | 39 765 | −8,30 | 68,67 | −247 212 | 2 730 663 | |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 166 | 43 365 | −4,76 | 67,64 | −146 508 | 2 933 209 | |
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −15 625 | 15 625 | −50,00 | ||||
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 31 250 | 31 250 | |||||
2021-12-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 15 625 | 45 531 | 52,25 | ||||
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −5 070 | 29 839 | −14,52 | 92,95 | −471 256 | 2 773 535 | |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −300 | 34 909 | −0,85 | 91,55 | −27 465 | 3 195 919 | |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 100 | 35 209 | −8,09 | 90,40 | −280 240 | 3 182 894 | |
2021-11-08 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 998 | 38 309 | −7,26 | 90,04 | −269 940 | 3 449 342 | |
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −15 625 | 15 625 | −50,00 | ||||
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 31 250 | 31 250 | |||||
2021-10-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 15 625 | 41 307 | 60,84 | ||||
2021-08-31 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −60 | 0 | −100,00 | ||||
2021-08-31 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 60 | 25 682 | 0,23 | 30,44 | 1 826 | 781 760 | |
2021-05-21 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −3 125 | 60 | −98,12 | ||||
2021-05-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 3 125 | 25 622 | 13,89 | 30,44 | 95 125 | 779 934 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −32 | 22 332 | −0,14 | 95,48 | −3 055 | 2 132 259 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 000 | 22 364 | −18,27 | 98,25 | −491 250 | 2 197 263 |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 000 | 27 364 | −3,53 | 100,91 | −100 910 | 2 761 301 | |
2021-05-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 544 | 28 364 | −5,16 | 100,29 | −154 848 | 2 844 626 | |
2021-04-14 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −602 | 29 908 | −1,97 | 111,88 | −67 352 | 3 346 107 |
2021-04-14 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 383 | 30 510 | −9,98 | 111,11 | −375 885 | 3 389 966 |
2021-04-14 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 515 | 33 893 | −9,40 | 109,88 | −386 228 | 3 724 163 |
2021-04-14 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −900 | 37 408 | −2,35 | 109,04 | −98 136 | 4 078 968 |
2021-04-07 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 6 818 | 6 818 | |||||
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −8 467 | 25 404 | −25,00 | ||||
2021-04-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 8 467 | 38 308 | 28,37 | ||||
2021-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −5 468 | 29 841 | −15,49 | 97,33 | −532 200 | 2 904 425 | |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 35 309 | −0,28 | 131,98 | −13 198 | 4 660 082 |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 35 409 | −1,67 | 131,39 | −78 834 | 4 652 389 |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −900 | 36 009 | −2,44 | 130,36 | −117 324 | 4 694 133 |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −600 | 36 909 | −1,60 | 129,17 | −77 502 | 4 767 536 |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 800 | 37 509 | −4,58 | 128,18 | −230 724 | 4 807 904 |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 900 | 39 309 | −4,61 | 127,10 | −241 490 | 4 996 174 |
2021-03-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 500 | 41 209 | −5,72 | 126,04 | −315 100 | 5 193 982 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −100 | 43 709 | −0,23 | 158,95 | −15 895 | 6 947 546 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 43 809 | −0,68 | 157,92 | −47 376 | 6 918 317 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −475 | 44 109 | −1,07 | 156,32 | −74 252 | 6 895 119 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 600 | 44 584 | −3,46 | 155,64 | −249 024 | 6 939 054 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −900 | 46 184 | −1,91 | 154,60 | −139 140 | 7 140 046 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −700 | 47 084 | −1,46 | 153,29 | −107 303 | 7 217 506 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 765 | 47 784 | −5,47 | 152,46 | −421 552 | 7 285 149 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −500 | 50 549 | −0,98 | 151,41 | −75 705 | 7 653 624 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −860 | 51 049 | −1,66 | 150,37 | −129 318 | 7 676 238 |
2021-02-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −200 | 51 909 | −0,38 | 149,18 | −29 836 | 7 743 785 |
2021-01-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 074 | 52 109 | −2,02 | 146,36 | −157 191 | 7 626 673 |
2021-01-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 185 | 53 183 | −3,95 | 145,73 | −318 420 | 7 750 359 |
2021-01-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 388 | 55 368 | −4,13 | 144,55 | −345 185 | 8 003 444 |
2021-01-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 953 | 57 756 | −3,27 | 143,73 | −280 705 | 8 301 270 |
2021-01-07 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −722 | 3 185 | −18,48 | |||
2021-01-07 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −261 | 0 | −100,00 | |||
2021-01-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −983 | 59 709 | −1,62 | 135,08 | −132 784 | 8 065 492 |
2021-01-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 722 | 60 692 | 1,20 | 30,44 | 21 978 | 1 847 464 |
2021-01-07 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 261 | 59 970 | 0,44 | 20,00 | 5 220 | 1 199 400 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −300 | 59 709 | −0,50 | 136,00 | −40 800 | 8 120 424 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 960 | 60 009 | −4,70 | 135,00 | −399 600 | 8 101 215 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −203 | 62 969 | −0,32 | 133,70 | −27 141 | 8 418 955 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 63 172 | −4,53 | 132,85 | −398 550 | 8 392 400 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 601 | 66 172 | −2,36 | 131,78 | −210 980 | 8 720 146 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 961 | 67 773 | −8,08 | 130,80 | −779 699 | 8 864 708 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 431 | 73 734 | −6,86 | 129,95 | −705 758 | 9 581 733 |
2020-12-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 169 | 79 165 | −2,67 | 128,81 | −279 389 | 10 197 244 |
2020-12-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −200 | 81 159 | −0,25 | ||||
2020-12-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −174 | 81 359 | −0,21 | ||||
2020-12-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −50 | 81 533 | −0,06 | ||||
2020-12-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −100 | 81 583 | −0,12 | ||||
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −50 | 81 683 | −0,06 | 120,63 | −6 032 | 9 853 420 | |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 000 | 81 733 | −2,39 | 119,77 | −239 540 | 9 789 161 | |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 585 | 83 733 | −1,86 | 118,84 | −188 361 | 9 950 830 | |
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −7 812 | 0 | −100,00 | ||||
2020-11-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 7 812 | 85 318 | 10,08 | ||||
2020-11-20 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −778 | 0 | −100,00 | ||||
2020-11-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 778 | 77 506 | 1,01 | 20,00 | 15 560 | 1 550 120 | |
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −420 | 0 | −100,00 | ||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 420 | 420 | |||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −3 906 | 3 907 | −49,99 | ||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −1 562 | 261 | −85,68 | ||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −172 | 76 728 | −0,22 | 100,27 | −17 246 | 7 693 517 | |
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 420 | 76 900 | 0,55 | ||||
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 3 906 | 76 480 | 5,38 | 30,44 | 118 899 | 2 328 051 | |
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 1 562 | 72 574 | 2,20 | 20,00 | 31 240 | 1 451 480 | |
2020-11-10 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −10 000 | 71 012 | −12,34 | 88,00 | −880 000 | 6 249 056 | |
2020-10-19 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 81 012 | −3,57 | 82,41 | −247 230 | 6 676 199 |
2020-09-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 84 012 | −3,45 | 72,01 | −216 030 | 6 049 704 |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 051 | 87 012 | −1,19 | 81,70 | −85 867 | 7 108 880 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −600 | 88 063 | −0,68 | 80,82 | −48 492 | 7 117 252 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 909 | 88 663 | −2,11 | 80,10 | −152 911 | 7 101 906 | |
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −7 812 | 7 812 | −50,00 | ||||
2020-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 7 812 | 90 572 | 9,44 | ||||
2020-08-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 82 760 | −3,50 | 81,73 | −245 190 | 6 763 975 |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −82 | 85 760 | −0,10 | 79,50 | −6 519 | 6 817 920 | |
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −400 | 85 842 | −0,46 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −200 | 0 | −100,00 | ||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 200 | 200 | |||||
2020-08-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 200 | 86 242 | 0,23 | ||||
2020-07-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −3 000 | 86 042 | −3,37 | 75,26 | −225 780 | 6 475 521 |
2020-06-16 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −400 | 89 042 | −0,45 | ||||
2020-06-09 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −385 | 1 823 | −17,44 | ||||
2020-06-09 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −3 125 | 7 813 | −28,57 | ||||
2020-06-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −385 | 89 442 | −0,43 | 79,47 | −30 596 | 7 107 956 | |
2020-06-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −3 125 | 89 827 | −3,36 | 79,54 | −248 562 | 7 144 840 | |
2020-06-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 385 | 92 952 | 0,42 | 20,00 | 7 700 | 1 859 040 | |
2020-06-09 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 3 125 | 92 567 | 3,49 | 30,44 | 95 125 | 2 817 739 | |
2020-05-29 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −917 | 2 208 | −29,34 | ||||
2020-05-29 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −13 108 | 778 | −94,40 | ||||
2020-05-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 917 | 89 442 | 1,04 | 20,00 | 18 340 | 1 788 840 | |
2020-05-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 13 108 | 88 525 | 17,38 | 20,00 | 262 160 | 1 770 500 | |
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 823 | 75 417 | −3,61 | 66,81 | −188 605 | 5 038 610 | |
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −7 813 | 15 624 | −33,34 | ||||
2020-05-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 7 813 | 78 240 | 11,09 | ||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −94 | 70 427 | −0,13 | 67,82 | −6 375 | 4 776 359 | |
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
M - Exercise | −332 | 0 | −100,00 | ||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Units |
A - Award | 332 | 332 | |||||
2020-05-22 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 332 | 70 521 | 0,47 | ||||
2020-05-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 69 918 | −2,78 | 58,25 | −116 500 | 4 072 724 |
2020-04-20 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 71 918 | −2,71 | 47,71 | −95 420 | 3 431 208 |
2020-04-13 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
A - Award | 33 870 | 33 871 | 3 387 000,00 | ||||
2020-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 73 918 | −2,63 | 44,57 | −89 140 | 3 294 525 |
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −300 | 75 918 | −0,39 | 45,68 | −13 704 | 3 467 934 | |
2020-03-11 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −2 488 | 76 218 | −3,16 | 44,52 | −110 766 | 3 393 225 | |
2020-03-02 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −7 813 | 23 437 | −25,00 | ||||
2020-03-02 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 7 813 | 78 706 | 11,02 | ||||
2020-02-18 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −1 562 | 10 938 | −12,50 | |||
2020-02-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −781 | 70 893 | −1,09 | 102,41 | −79 982 | 7 260 152 |
2020-02-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 781 | 71 674 | −3,74 | 100,00 | −278 100 | 7 167 400 |
2020-02-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 74 455 | −2,62 | 98,12 | −196 240 | 7 305 525 |
2020-02-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 1 562 | 76 455 | 2,09 | 30,44 | 47 547 | 2 327 290 |
2020-02-06 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −2 000 | 74 893 | −2,60 | 90,00 | −180 000 | 6 740 370 |
2020-01-17 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | X | −778 | 13 886 | −5,31 | |||
2020-01-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −919 | 76 893 | −1,18 | 84,88 | −78 005 | 6 526 678 |
2020-01-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −450 | 77 812 | −0,57 | 84,13 | −37 858 | 6 546 324 |
2020-01-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −5 409 | 78 262 | −6,46 | 83,06 | −449 272 | 6 500 442 |
2020-01-17 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | X | 778 | 83 671 | 0,94 | 20,00 | 15 560 | 1 673 420 |
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −200 | 82 893 | −0,24 | ||||
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
G - Gift | −200 | 82 893 | −0,24 | ||||
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −10 000 | 12 500 | −44,44 | ||||
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −261 | 3 125 | −7,71 | ||||
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −777 | 0 | −100,00 | ||||
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −11 038 | 83 293 | −11,70 | 58,00 | −640 204 | 4 830 994 | |
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 000 | 94 331 | 11,86 | 30,44 | 304 400 | 2 871 436 | |
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 261 | 84 331 | 0,31 | 20,00 | 5 220 | 1 686 620 | |
2019-12-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 777 | 84 070 | 0,93 | 9,08 | 7 055 | 763 356 | |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −15 000 | 22 500 | −40,00 | ||||
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −25 231 | 777 | −97,01 | ||||
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −15 000 | 83 293 | −15,26 | 60,00 | −900 000 | 4 997 580 | |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 15 000 | 98 293 | 18,01 | 30,44 | 456 600 | 2 992 039 | |
2019-12-05 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 25 231 | 83 293 | 43,46 | 9,08 | 229 097 | 756 300 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −5 426 | 58 062 | −8,55 | 56,22 | −305 050 | 3 264 246 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −10 100 | 63 488 | −13,73 | 55,88 | −564 388 | 3 547 709 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −15 625 | 31 250 | −33,33 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −15 625 | 31 250 | −33,33 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 31 250 | 62 500 | 100,00 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −9 114 | 3 386 | −72,91 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −22 671 | 14 664 | −60,72 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −1 491 | 26 008 | −5,42 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 15 625 | 73 588 | 26,96 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 15 625 | 73 588 | 26,96 | ||||
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −33 276 | 42 338 | −44,01 | 56,38 | −1 876 101 | 2 387 016 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 31 785 | 75 614 | 72,52 | 20,00 | 635 700 | 1 512 280 | |
2019-11-27 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 1 491 | 43 829 | 3,52 | 9,08 | 13 538 | 397 967 | |
2019-11-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 42 338 | −3,42 | 58,70 | −88 050 | 2 485 241 |
2019-10-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 43 283 | −3,35 | 38,15 | −57 225 | 1 651 246 |
2019-09-30 |
|
4 | CDLX |
Cardlytics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | −10 000 | 27 499 | −26,67 | ||||
2019-09-30 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 10 000 | 44 783 | 28,75 | 9,08 | 90 800 | 406 630 | |
2019-09-23 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 34 783 | −4,13 | 35,41 | −53 115 | 1 231 666 |
2019-08-28 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 31 250 | 31 250 | |||||
2019-08-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 36 283 | −3,97 | 32,57 | −48 855 | 1 181 737 |
2019-07-24 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 37 783 | −3,82 | 27,46 | −41 190 | 1 037 521 |
2019-06-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −1 500 | 39 283 | −3,68 | 24,05 | −36 075 | 944 756 |
2019-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −820 | 39 839 | −2,02 | 16,52 | −13 546 | 658 140 |
2019-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −831 | 40 659 | −2,00 | 16,30 | −13 545 | 662 742 |
2019-03-29 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −857 | 41 490 | −2,02 | 15,79 | −13 532 | 655 127 |
2019-03-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −862 | 42 347 | −1,99 | 15,70 | −13 533 | 664 848 |
2019-03-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −887 | 43 209 | −2,01 | 15,26 | −13 536 | 659 369 |
2019-03-26 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −846 | 44 096 | −1,88 | 16,00 | −13 536 | 705 536 |
2019-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −851 | 44 942 | −1,86 | 15,91 | −13 539 | 715 027 |
2019-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −874 | 45 793 | −1,87 | 15,49 | −13 538 | 709 334 |
2019-03-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −866 | 46 667 | −1,82 | 15,63 | −13 536 | 729 405 |
2019-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −871 | 47 533 | −1,80 | 15,54 | −13 535 | 738 663 |
2019-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −879 | 48 404 | −1,78 | 15,39 | −13 528 | 744 938 |
2019-03-18 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −884 | 49 283 | −1,76 | 15,32 | −13 543 | 755 016 |
2019-03-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −859 | 50 167 | −1,68 | 15,75 | −13 529 | 790 130 |
2019-03-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −846 | 51 026 | −1,63 | 16,00 | −13 536 | 816 416 |
2019-03-13 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | X | −849 | 51 872 | −1,61 | 15,95 | −13 542 | 827 358 |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 | 52 721 | 0,00 | 13,76 | −14 | 725 441 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −13 969 | 52 722 | −20,95 | 13,33 | −186 207 | 702 784 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
M - Exercise | −75 000 | 0 | −100,00 | ||||
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −12 900 | 66 691 | −16,21 | 13,68 | −176 472 | 912 333 | |
2018-12-12 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
M - Exercise | 75 000 | 79 591 | 1 633,63 | ||||
2018-12-07 |
|
4 | CDLX |
Cardlytics, Inc.
Performance Stock Unit |
A - Award | 75 000 | 75 000 | |||||
2018-08-21 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
S - Sale | −1 202 | 2 668 | −31,06 | 20,66 | −24 833 | 55 121 | |
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
C - Conversion | −3 870 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 1 087 | 3 870 | 39,06 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −1 087 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 1 862 | 2 783 | 202,17 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −1 862 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Series G' Redeemable Convertible Preferred Stock |
M - Exercise | 921 | 921 | |||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Restricted Stock Unit |
M - Exercise | −921 | 0 | −100,00 | ||||
2018-02-15 |
|
4 | CDLX |
Cardlytics, Inc.
Common Stock |
C - Conversion | 3 870 | 3 870 | |||||
2014-04-02 |
|
4 | GKNT |
Geeknet, Inc
Restricted Stock Units |
M - Exercise | −903 | 1 806 | −33,33 | ||||
2014-04-02 |
|
4 | GKNT |
Geeknet, Inc
Common Stock |
F - Taxes | −291 | 612 | −32,23 | 14,02 | −4 080 | 8 580 | |
2014-04-02 |
|
4 | GKNT |
Geeknet, Inc
Common Stock |
M - Exercise | 903 | 903 | |||||
2013-04-02 |
|
4 | GKNT |
Geeknet, Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 4 514 | 4 514 | |||||
2013-04-02 |
|
4 | GKNT |
Geeknet, Inc
Restricted Stock Units |
A - Award | 2 709 | 2 709 | |||||
2012-09-13 |
|
4 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
S - Sale | −838 | 48 877 | −1,69 | 4,45 | −3 729 | 217 503 | |
2012-09-12 |
|
4 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
A - Award | 19 462 | 49 715 | 64,33 | ||||
2012-08-28 |
|
4 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
D - Sale to Issuer | −14 182 | 30 253 | −31,92 | ||||
2012-07-19 |
|
5 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
D - Sale to Issuer | −11 607 | 44 885 | −20,55 | ||||
2012-06-14 |
|
4 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
S - Sale | −4 711 | 56 492 | −7,70 | 4,00 | −18 844 | 225 968 | |
2012-06-13 |
|
4 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
S - Sale | −3 267 | 61 203 | −5,07 | 3,85 | −12 578 | 235 632 | |
2012-06-13 |
|
4 | CCUR |
CONCURRENT COMPUTER CORP/DE
Common Stock |
S - Sale | −6 140 | 64 470 | −8,70 | 3,90 | −23 946 | 251 433 |